Literature DB >> 17440721

Carbon monoxide signalling reduces photocarcinogenesis in the hairless mouse.

Munif Allanson1, Vivienne E Reeve.   

Abstract

Exposure of the skin of mice to UVA (320-400 nm) radiation has been shown to provide protection against the immunosuppressive effects of UVB (290-320 nm) radiation. The UVA protection was mediated via the UVA induction of the stress protein heme oxygenase-1, and its enzymatic product carbon monoxide (CO). Because UVB-induced immunosuppression is an accompanying and prerequisite feature of the promotion phase of photocarcinogenesis, the potential for immunoprotective CO to act as an anti-skin cancer agent was tested in this study. Groups of female albino Skh:hr-1 hairless mice were irradiated chronically with daily minimally erythemogenic doses of solar simulated UV radiation (SSUV) during a 10 week-period to induce photocarcinogenesis. The effect of repeated topical application of lotions containing a CO-releasing molecule (CORM-2; tricarbonyldichlororuthenium (II) dimer) at 250 or 500 microM, that had previously been shown in short-term experiments to provide photoimmune protection in mice, was measured. Tumor development was monitored for 29 weeks. Topical CORM-2 treatment was observed to reduce the acute and chronic inflammatory erythema reaction compared with control irradiated mice that did not receive CORM-2 lotions, and to reduce the chronic epidermal hyperplasia accompanying tumor outgrowth. The CORM-2 treatments provided a significant moderate inhibition of early tumor appearance dose-dependently, significantly reduced the average tumor multiplicity, increased the regression of established tumors dose-dependently, and inhibited the formation of large locally invasive tumors. The CORM-2 treatments also reduced the expression of immunosuppressive IL-10 in the uninvolved epidermis and dermis of tumor-bearing mice, and enhanced immunopotentiating epidermal IL-12 expression. Therefore CO signalling was revealed to have previously unrecognized anti-carcinogenic functions in the skin, consistent with a protective modulation of the epidermal cytokines. This is a novel observation that also implies that the UVA waveband that produces CO physiologically in exposed skin, might likewise be found to have an anti-photocarcinogenic action.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440721     DOI: 10.1007/s00262-007-0324-1

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  11 in total

Review 1.  Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis.

Authors:  Joydeb Kumar Kundu; Young-Joon Surh
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

Review 2.  The therapeutic potential of carbon monoxide.

Authors:  Roberto Motterlini; Leo E Otterbein
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

Review 3.  Therapeutic potential of carbon monoxide in multiple sclerosis.

Authors:  P Fagone; K Mangano; M Coco; V Perciavalle; G Garotta; C C Romao; F Nicoletti
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

4.  Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein.

Authors:  Leo E Otterbein; Andreas Hedblom; Clair Harris; Eva Csizmadia; David Gallo; Barbara Wegiel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-17       Impact factor: 11.205

Review 5.  Use of carbon monoxide as a therapeutic agent: promises and challenges.

Authors:  Roberta Foresti; Mohamed G Bani-Hani; Roberto Motterlini
Journal:  Intensive Care Med       Date:  2008-02-20       Impact factor: 17.440

6.  Long-term exposure to commercially available sunscreens containing nanoparticles of TiO2 and ZnO revealed no biological impact in a hairless mouse model.

Authors:  Megan J Osmond-McLeod; Yalchin Oytam; Anthony Rowe; Fariborz Sobhanmanesh; Gavin Greenoak; Jason Kirby; Elizabeth F McInnes; Maxine J McCall
Journal:  Part Fibre Toxicol       Date:  2016-08-17       Impact factor: 9.400

Review 7.  Aspects of Carbon Monoxide in Form of CO-Releasing Molecules Used in Cancer Treatment: More Light on the Way.

Authors:  Malamati Kourti; Wen G Jiang; Jun Cai
Journal:  Oxid Med Cell Longev       Date:  2017-02-13       Impact factor: 6.543

8.  Impact of carbon monoxide poisoning on the risk of breast cancer.

Authors:  Chien-Cheng Huang; Chung-Han Ho; Yi-Chen Chen; Chien-Chin Hsu; Hung-Jung Lin; Yu-Feng Tian; Jhi-Joung Wang; How-Ran Guo
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

9.  Targeting PRPK and TOPK for skin cancer prevention and therapy.

Authors:  Eunmiri Roh; Mee-Hyun Lee; Tatyana A Zykova; Feng Zhu; Janos Nadas; Hong-Gyum Kim; Ki Beom Bae; Yan Li; Yong Yeon Cho; Clara Curiel-Lewandrowski; Janine Einspahr; Sally E Dickinson; Ann M Bode; Zigang Dong
Journal:  Oncogene       Date:  2018-06-14       Impact factor: 9.867

10.  Carbon Monoxide Partially Mediates Protective Effect of Resveratrol Against UVB-Induced Oxidative Stress in Human Keratinocytes.

Authors:  Janice N Averilla; Jisun Oh; Jong-Sang Kim
Journal:  Antioxidants (Basel)       Date:  2019-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.